Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Clinical trial NCT07770802 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07770802
Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2026-10-01
Primary completion: 2026-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.